Genetic mutations in cancer cells can lead to the production of abnormal proteins that drive cancer growth. However, these same mutations can also create dependencies on certain pathways or molecules. For example, cancers with mutations in the EGFR gene may be particularly vulnerable to drugs that inhibit EGFR signaling.
